Seminars in Radiation Oncology
Volume 18, Issue 3 , Pages 194-200 , July 2008

The Impact of Technology on Health Care Cost and Policy Development

  • Paul E. Wallner, DO

      Affiliations

    • 21st Century Oncology, Inc, Fort Myers, FL.
    • Corresponding Author InformationAddress reprint requests to Paul E. Wallner, DO, 140 Fellswood Drive, Moorestown, NJ 08057.
    • ,
  • Andre Konski, MD, MBA, MA

      Affiliations

    • Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA.

References 

  1. Available at: http://www.kff.org/insurancesnapshot/chcm030807oth.cfm. Accessed July 2007
  2. Congressional Budget Office Report, U.S. Government Printing Office, 2007
  3. Rettig RA. Medical innovation duels cost containment. Health Aff (Millwood). 1994;13:7–27
  4. Washington Post, p A24, August 31, 2006
  5. Bartlett DL, Steele . JB So much for drugs. 2004;45–49Time Magazine February 2
  6. Devey GB. Role of technology in the cost of health care: A new parameter in research and clinical applications. Proc Soc Photo Opt Instrum Eng. 1994;2307:158–165
  7. Young DA. Role of technology in the cost of health care: is there a conflict between improved health delivery and lowering costs. Proc Soc Photo Opt Instrum Eng. 1994;2307:117–123
  8. McClellan MB. Technology and innovation: Their effects on cost growth of healthcare. 2003;Before the Joint Economic Committee, US Congress, July 9
  9. Morgan MG. Death by congressional ignorance. 1995;Pittsburgh Post-Gazette August 2
  10. Available at: http://www.fda.gov/cdrh/devadvice/overview.html. Accessed July 2007
  11. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm. Accessed
  12. Available at: http://www.fda.gov/cdrh/devadvice/313.html. Accessed
  13. Available at: http://scholar.lib.vt.edu/ejournals/SPT/v4n4/mohr.html. Accessed
  14. Available at: http://jcflowers1.iweb.bsu.edu/rlo/modteachingta.htm. Accessed July, 2007
  15. Porter AL, Rossinni F, Carpenter SR, et al. Strategies for particular assessments: Bounding and techniques, in A Guidebook for Technology Assessment and Impact Analysis. 1980;New York, North Holland
  16. Available at: http://jcflowers1.iweb.bsu.edu/rlo/modteachingta.htm. Accessed July, 2007
  17. Armstrong JE, Harman WW. Strategies for Conducting Technology Assessments. Boulder, CO: Westview Press; 1980;
  18. Porter AL, Rossinni F, Carpenter SR, et al. A Guidebook for Technology Assessment and Impact Analysis. 1980;New York, North Holland
  19. Bridges JF, Jones C. Patient-based health technology assessment: A vision of the future. Int J Technol Assess Health Care. 2004;23:30–35
  20. Culyer AJ. Involving stakeholders in healthcare decisions — the experience of the National Institute for Health and Clinical Excellence (NICE) in England and Wales. Health Quality. 2005;8:56–60
  21. Shah SG, Robinson I. User involvement in healthcare technology development and assessment: structured literature review. Int J Health Care Qual Assur Inc Leadersh Health Serv. 2006;19:500–515
  22. Available at: http://www.hayesinc.com/. Accessed July, 2007
  23. Roper WL. Medicare, Medicaid, and health care quality. Health Aff (Millwood). 2005;5:331–332
  24. Fernandopulle R, Ferris T, Epstein A, et al. A research agenda for bridging the ‘quality chasm’. Health Aff (Millwood). 2003;22:178–190
  25. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–1632
  26. Herzlinger RE, Parsa-Parsi R. Consumer-driven health care. J Am Med Assoc. 2004;292:1213–1220
  27. Available at: http://www.commonwealthfund.org/publications/publications_show.htm?doc_id=449510. Accessed July, 2007
  28. Ginsburg PB. Controlling health care costs. N Engl J Med. 2004;351:1591–1593
  29. Raab GG, Parr DH. From medical invention to clinical practice: The reimbursement challenge facing new device procedures and technology—Part 2: Coverage. J Am Coll Radiol. 2006;3:772–777
  30. Raab GG, Parr DH. From medical invention to clinical practice: The reimbursement challenge facing new device procedures and technology—Part 3: Payment. J Am Coll Radiol. 2006;3:842–850
  31. Pearson SD, Miller FG, Emanuel EJ. Medicare's requirement for research participation as a condition of coverage (Is it ethical?). JAMA. 2006;296:988–991
  32. Tunis SR. Reflections on science, judgment, and value in evidence-based decision-making: A conversation with David Eddy. Health Aff (Millwood). 2007;26:500–515

PII: S1053-4296(08)00019-2

doi: 10.1016/j.semradonc.2008.01.007

Seminars in Radiation Oncology
Volume 18, Issue 3 , Pages 194-200 , July 2008

Article Tools